A Mitochondria-targeted Caffeic Acid Derivative Reverts Cellular and Mitochondrial Defects in Human Skin Fibroblasts from Male Sporadic Parkinson’s Disease Patients

targeting-mitochondria-2021-Paulo OliveiraDr. Paulo J. Oliveira from University of Coimbra, Portugal will join the Targeting Mitochondria 2021 congress and will present a talk entitled A Mitochondria-targeted Caffeic Acid Derivative Reverts Cellular and Mitochondrial Defects in Human Skin Fibroblasts from Male Sporadic Parkinson’s Disease Patients" the congress.

 

Dr. Oliveire highlighted: "We are developing a lead mitochondria-targeted hydroxycinnamic acid derivative with potential use in different diseases with a mitochondrial dysfunction component.  This talk will focus on our recent study investigating the effects of our novel molecule on skin fibroblasts from sporadic Parkinson's Disease (PD) patients. Our data shows a positive impact of this molecule on mitochondrial function and redox signaling, paving the way to further in vivo studies to validate this molecule in a PD model".

 

 

Targeting Mitochondria 2021 Congress
October 27-29, 2021
Berlin, Germany & Virtual Congress
www.targeting-mitochondria.com